During the past decade, Hôpital Pasteur conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 20 clinical trials were completed, i.e. on average, 19.2% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 12 clinical trials were completed. i.e. 22.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Pasteur" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "Centre Hospitalier Universitaire de Nice" with 8 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 7 trials sponsored and "Hospices Civils de Lyon" with 7 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Pasteur" #1 collaborator was "Ministry of Health, France" with 11 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator, "Prothena Biosciences Limited" with 2 trials as a collaborator, "ANARLF Network" with 1 trials as a collaborator and "AZUREA Network (www.azurea.org)" with 1 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Pasteur" are "Multiple Sclerosis" (9 trials), "Amyotrophic Lateral Sclerosis" (7 trials), "Idiopathic Pulmonary Fibrosis" (7 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Hôpital Pasteur" in a lesser frequency.

Most popular intervention types in "Hôpital Pasteur" are "Drug" (89 trials), "Other" (24 trials), "Device" (20 trials), "Biological" (11 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Nintedanib" (7 trials), "AT2221" (2 trials), "ATB200" (2 trials) and "Apixaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Pasteur" are 142 trials for "All" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Pasteur". 3 are not yet recruiting, 30 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Hôpital Pasteur, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Pasteur, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 27 trials that are defined as “Not Applicable".

Hôpital Pasteur has several departments that took part in Clinical trials: "GCS des hôpitaux pédiatriques" - 2 trials